Arbutamine
Alternative Names: Genesa; GP 21213Latest Information Update: 14 Jul 2010
At a glance
- Originator SICOR
- Class Cardiotonics; Catecholamines; Small molecules
- Mechanism of Action Alpha 1 adrenergic receptor agonists; Beta adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Coronary artery disease
Most Recent Events
- 14 Jul 2010 No development reported - Preregistration for Coronary artery disease in Canada (IV)
- 14 Jul 2010 No development reported - Preregistration for Coronary artery disease in Switzerland (IV)
- 28 Jan 2004 SICOR has been acquired by Teva Pharmaceutical Industries